Catapult Award supports researchers conducting Phase 1 and Phase 2 pediatric cancer trials, moving promising laboratory findings into patient testing to advance better, less-toxic treatments for children.
Acceleration Initiative Award supports researchers pursuing translational and preclinical pediatric cancer treatment research to overcome development barriers and reach clinical trials within three years.
Young Investigator Award supports early-career scientists pursuing innovative pediatric cancer research, including therapeutic target discovery, to advance better, safer treatments for children with cancer.
Clinical Trial Grant - Cannonball Kids' cancer Foundation supports researchers developing innovative pediatric cancer trials to expand treatment options, improve quality of life, and relieve symptoms.
A Collaborative Pediatric Cancer Research Awards Program supports fellows, investigators, and consortia studying childhood cancers to advance discoveries, safer treatments, and patients’ quality of life.
Childhood Cancer Research Grants support investigators, including beginning scientists and physician-scientists, in targeted research to improve childhood cancer survival while protecting long-term health.